Barbara Leuchs

2.8k citations

51 papers · 1.8k indexed · h-index 22

Impact in

Genetics top 2%
- Virus-based gene therapy research
Infectious Diseases top 5%
- Parvovirus B19 Infection Studies

Papers in ⓘ

Genetics 46
- Virus-based gene therapy research 45
Biotechnology 8
- Cancer Research and Treatments 8

Co-authors: Jean Rommelaere (31 shared papers)Jürgen A. Kleinschmidt (8 shared papers)Hugo A. Katus (8 shared papers)Oliver J. Müller (8 shared papers)Florian Sonntag (1 shared paper)Roger Fischer (1 shared paper)Sven T. Pleger (2 shared papers)Zahari Raykov (4 shared papers)
Journals: Viruses (4 papers)International Journal of Cancer (4 papers)Journal of Virology (4 papers)Cardiovascular Research (3 papers)Applied Microbiology and Biotechnology (3 papers)
Partner nations: Germany France United States

In The Last Decade

Barbara Leuchs

50 papers receiving 1.7k citations

Peers

Countries citing papers authored by Barbara Leuchs

Since Specialization

Citations

This map shows the geographic impact of Barbara Leuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Leuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Leuchs more than expected).

Fields of papers citing papers by Barbara Leuchs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Leuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Leuchs. The network helps show where Barbara Leuchs may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Leuchs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Leuchs Line = papers co-authored together Barbara Leuchs links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adeno-Associated Virus Type 2 Capsids with Externalized VP1/VP2 Trafficking Domains Are Generated prior to Passage through the Cytoplasm and Are Maintained until Uncoating Occurs in the Nucleus Journal of Virology ·Florian Sonntag, Svenja Bleker, Barbara Leuchs, Roger Fischer, Jürgen A. Kleinschmidt	2006	215
2	Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model Science Translational Medicine ·Sven T. Pleger, Changguang Shan, Jan Ksienzyk, Raffi Bekeredjian, Peter Boekstegers, Rabea Hinkel, Stefanie Schinkel, Barbara Leuchs, Jochen Ludwig, Gang Qiu, Christophe Weber, Philip Raake, Walter J. Koch, Hugo A. Katus, Oliver J. Müller, Patrick Most	2011	167
3	Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol BMC Cancer ·Karsten Geletneky, Johannes Huesing, Jean Rommelaere, Joerg R. Schlehofer, Barbara Leuchs, Michael Dahm, Ottheinz Krebs, Magnus von Knebel Doeberitz, Bernard Huber, Jacek Hajda	2012	130
4	Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors Cardiovascular Research ·Oliver J. Müller, Barbara Leuchs, Sven T. Pleger, David R. Grimm, Wolfgang M. Franz, Hugo A. Katus, J A Kleinschmidt	2006	125
5	Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV Clinical Cancer Research ·Assia L. Angelova, Marc Aprahamian, Svitlana P. Grekova, Amor Hajri, Barbara Leuchs, Nathalia A. Giese, Christiane Dinsart, Alexia Herrmann, Ginette Balboni, Jean Rommelaere, Zahari Raykov	2009	81
6	Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses Molecular Therapy — Methods & Clinical Development ·Guy Ungerechts, Sascha Bossow, Barbara Leuchs, Per Sonne Holm, Jean Rommelaere, Matt Coffey, Rob Coffin, John C. Bell, Dirk M. Nettelbeck	2016	81
7	Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening Molecular Therapy — Nucleic Acids ·Angelika Alonso, Eileen Reinz, Barbara Leuchs, Jürgen A. Kleinschmidt, Marc Fatar, Bart Geers, Ine Lentacker, Michael G. Hennerici, Stefaan C. De Smedt, Stephen Meairs	2013	74
8	Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase Cardiovascular Research ·Stanislas Werfel, Andreas Jungmann, Lorenz Lehmann, Jan Ksienzyk, Raffi Bekeredjian, Ziya Kaya, Barbara Leuchs, Alfred Nordheim, Johannes Backs, Stefan Engelhardt, Hugo A. Katus, Oliver J. Müller	2014	65
9	Intranasal Vaccination with Recombinant Adeno-Associated Virus Type 5 against Human Papillomavirus Type 16 L1 Journal of Virology ·Dirk Kuck, Tobias Lau, Barbara Leuchs, Andrea Kern, Martin Müller, Lutz Gissmann, Jürgen A. Kleinschmidt	2006	54
10	Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library Gene Therapy ·Yanling Ying, Oliver J. Müller, Caroline Goehringer, Barbara Leuchs, Martin Trepel, Hugo A. Katus, Jürgen A. Kleinschmidt	2010	53
11	TSC22D4 is a molecular output of hepatic wasting metabolism EMBO Molecular Medicine ·Allan Jones, Kilian Friedrich, Maria Rohm, Michaela Schäfer, Carolyn Algire, Philipp Kulozik, Oksana Seibert, Karin Müller‐Decker, Tjeerd Sijmonsma, Daniela Strzoda, Carsten Sticht, Norbert Gretz, Geesje M. Dallinga‐Thie, Barbara Leuchs, Manfred Kögl, Wolfgang Stremmel, Mauricio Berriel Díaz, Stephan Herzig	2013	47
12	Protocol for Efficient Generation and Characterization of Adeno-Associated Viral Vectors Human Gene Therapy Methods ·Andreas Jungmann, Barbara Leuchs, Jean Rommelaere, Hugo A. Katus, Oliver J. Müller	2017	46
13	Intranasal Vaccination with AAV5 and 9 Vectors Against Human Papillomavirus Type 16 in Rhesus Macaques Human Gene Therapy ·Karen Nieto, Christiane Stahl‐Hennig, Barbara Leuchs, Martin Müller, Lutz Gissmann, Jürgen A. Kleinschmidt	2012	40
14	A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol BMC Cancer ·Jacek Hajda, Monika Lehmann, Ottheinz Krebs, Meinhard Kieser, Karsten Geletneky, Dirk Jäger, Michael Dahm, Bernard Huber, Tilman Schöning, Oliver Sedlaczek, Albrecht Stenzinger, Niels Halama, Volker Daniel, Barbara Leuchs, Assia L. Angelova, Jean Rommelaere, Christine E. Engeland, Christoph Springfeld, Guy Ungerechts	2017	40
15	Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity International Journal of Cancer ·Zahari Raykov, Svetlana P. Grekova, Barbara Leuchs, Marc Aprahamian, Jean Rommelaere	2008	39
16	Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells International Journal of Cancer ·Jeannine Lacroix, Barbara Leuchs, Junwei Li, Georgi Hristov, Hedwig E. Deubzer, Andreas E. Kulozik, Jean Rommelaere, Jörg R. Schlehofer, Olaf Witt	2010	33
17	Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1 BMC Cancer ·Markus Moehler, Maike Sieben, Susanne Roth, Franziska Springsguth, Barbara Leuchs, Maja Zeidler, Christiane Dinsart, Jean Rommelaere, Peter R. Galle	2011	32
18	Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer Cancer Biology & Therapy ·Svitlana P. Grekova, Marc Aprahamian, Laurent Daeffler, Barbara Leuchs, Assia L. Angelova, Thomas Giese, Angel S. Galabov, Anette Heller, Nathalia A. Giese, Jean Rommelaere, Zahari Raykov	2011	32
19	Retargeting of Rat Parvovirus H-1PV to Cancer Cells through Genetic Engineering of the Viral Capsid Journal of Virology ·Xavier Allaume, Nazim El‐Andaloussi, Barbara Leuchs, Serena Bonifati, Amit Kulkarni, Tiina Marttila, Johanna K. Kaufmann, Dirk M. Nettelbeck, Jürgen A. Kleinschmidt, Jean Rommelaere, Antonio Marchini	2012	30
20	Regression of Glioma in Rat Models by Intranasal Application of Parvovirus H-1 Clinical Cancer Research ·Irina Kiprianova, Nadja Thomas, A. Ayache, M. Dominik Fischer, Barbara Leuchs, Michèle Klein, Jean Rommelaere, Jörg R. Schlehofer	2011	28

About Barbara Leuchs

Barbara Leuchs is a scholar working on Genetics, Biotechnology, Infectious Diseases, Animal Science and Zoology and Oncology, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (45 papers), CAR-T cell therapy research (14 papers), RNA Interference and Gene Delivery (11 papers), Parvovirus B19 Infection Studies (10 papers), Animal Virus Infections Studies (8 papers), Cancer Research and Treatments (8 papers), Viral Infections and Immunology Research (7 papers) and Viral gastroenteritis research and epidemiology (6 papers). The work is most often cited by research in Genetics (1.1k citations), Infectious Diseases (343 citations), Oncology (470 citations), Animal Science and Zoology (163 citations) and Molecular Biology (942 citations). Barbara Leuchs has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Jean Rommelaere, Jürgen A. Kleinschmidt, Hugo A. Katus, Oliver J. Müller, Florian Sonntag, Roger Fischer, Sven T. Pleger, Zahari Raykov, Karsten Geletneky and Jacek Hajda. Their work appears in journals such as Viruses, International Journal of Cancer, Journal of Virology, Cardiovascular Research and Applied Microbiology and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact